Back to today’s briefing

Story perspectives

Moderna Opens £1 Billion mRNA Plant Near Oxford

9/25/2025

23 5

Summary

Story summary

Moderna, Inc. opened the United Kingdom's mRNA plant near Oxford.
The project involves a £1 billion investment to boost vaccine production.
Capacity is 100 million doses annually, scalable to 250 million for future outbreaks.
Moderna will run National Health Service (NHS) trials for new vaccines and therapies, becoming the largest private sponsor of clinical trials in the United Kingdom.

1 of 1

Story summary

Moderna, Inc. opened the United Kingdom's mRNA plant near Oxford.
The project involves a £1 billion investment to boost vaccine production.
Capacity is 100 million doses annually, scalable to 250 million for future outbreaks.
Moderna will run National Health Service (NHS) trials for new vaccines and therapies, becoming the largest private sponsor of clinical trials in the United Kingdom.